European survey of hepatitis B vaccination policies for healthcare workers

European Journal of Public Health

Volumn 21, Issue 3, 2011, Pages 338-343

  De Schryver, Antoon ^a,b   Claesen, Bieke ^b   Meheus, André ^a   Van Sprundel, Marc ^a   François, Guido ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b EXTERNAL SERVICE FOR PREVENTION AND PROTECTION AT WORK   (Belgium)

Author keywords

cross sectional survey; European countries; health care workers; hepatitis B virus; vaccination policy

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE;

ARTICLE; BLOOD; CROSS-SECTIONAL STUDY; EUROPE; EUROPEAN UNION; EVALUATION; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LEGAL ASPECT; QUESTIONNAIRE; SEROLOGY; STATISTICS; VACCINATION;

CROSS-SECTIONAL STUDIES; EUROPE; EUROPEAN UNION; EVALUATION STUDIES AS TOPIC; HEALTH PERSONNEL; HEALTH POLICY; HEALTH SURVEYS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMANS; QUESTIONNAIRES; SEROLOGIC TESTS; VACCINATION;

EID: 79956197737     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckq122     Document Type: Review

References (23)

1. FitzSimons D, François G, De Carli G, et al. Hepatitis B virus, hepatitis C virus, and other blood-borne infections in healthcare workers: guidelines for prevention, and management. Occup Environ Med 2008;65:446-51. (Pubitemid 351969694)
2. Papaevangelou G, Roumeliotou-Karayannis A. New vaccines against hepatitis B. Eur J Epidemiol 1987;3:1-4. (Pubitemid 17058337)
3. European Union. Directive 2000/54/EC of the European Parliament and of the Council of 18 September 2000 on the protection of workers from risks related to exposure to biological agents at work (seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC). Official J L 262,17/10/2000 P.0021-0045.
4. Gunson R, Shouval D, Roggendorf M, et al. Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol 2003;27:213-30. (Pubitemid 36870896)
5. Cashman C, Slovak A. The occupational medicine agenda: routes and standards of specialization in occupational medicine in Europe. Occup Med 2005;55:308-11. (Pubitemid 41444323)
6. World Health Organization. The World Health Report 2006. Geneva: WHO, 2007.
7. EUROSTAT. Europe in figures - Eurostat Yearbook 2008. Luxembourg: European Communities, 2008.
8. Campins M, Hernandez MJ, editors. Grupo De trabajo EPINETAC (EPINET Study). Estudio y seguimiento del Riesgo Biolò gico en el Personal Sanitario. Sociedad Española De Medicina Preventiva. Madrid: Salud Pù blica e Higiene, 2002.
9. Ganczak M, Milona M, Szych Z. The comparison of the frequency of occupational exposures to blood-borne pathogens reported by doctors and nurses from surgical wards. [Article in Polish]. Problemy Higieny 2003;80:31-7.
10. Gyawali P, Rice PS, Tilzey AJ. Exposure to blood viruses and the hepatitis B status among healthcare workers in inner London. Occup Environ Med 1998;55:570-2. (Pubitemid 28393917)
11. Stroffolini T, Coppola R, Carvelli C, et al. Increasing hepatitis B vaccination coverage among healthcare workers in Italy 10 years apart. Dig Liv Dis 2008;40:275-7.
12. Vranckx R, Jacques P, De Schryver A, Moens G. Hepatitis B vaccination coverage in Belgian health care workers. Infection 2004;32:278-81. (Pubitemid 39319144)
13. Smith NA. Management of hepatitis B immunizations and blood exposure incidents in primary care. Occup Med 2004;54:231-7. (Pubitemid 38877861)
14. Simard EP, Miller JT, George PA, et al. Hepatitis B vaccination coverage levels among healthcare workers in the United States, 2002-2003. Infect Control Hosp Epidemiol 2007;28:783-90. (Pubitemid 47055916)
15. Paton S, Zou S, Giulivi A. More should be done to protect surgical patients from intraoperative hepatitis B infection. Infect Control Hosp Epidemiol 2002;23:1.
16. World Health Organization. Healthcare worker safety. Aide-mémoire for a strategy to protect health workers from infection. WHO/EHT/03.11. Geneva: WHO, 2003.
17. Joussemet M, Depaquit J, Nicaud E, et al. Fall in the seroprevalence of hepatitis A in French youth. Gastroenterol Clin Biol 1999;23:447-55.
18. Termorshuizen F, Dorigo-Zetsma JW, De Melker HE, et al. The prevalence of antibodies to hepatitis A virus and its determinants in The Netherlands: a population-based survey. Epidemiol Infection 2000;124:459-66. (Pubitemid 30623863)
19. Morris-Cunnington MC, Edmunds WJ, Miller E, Brown DW. A population-based seroprevalence study of hepatitis A virus using oral fluid in England and Wales. Am J Epidemiol 2004;159:786-94. (Pubitemid 38656136)
20. European Consensus Group on Hepatitis B Immunity. Are booster immunisations needed for lifelong hepatitis B immunity? Lancet 2000;355:561-5.
21. Cardell K, Akerlind B, Sällberg M, Frydén A. Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine. J Infect Dis 2008;198:299-304.
22. European Parliament resolution of 11 February 2010 on the proposal for a Council directive implementing the Framework Agreement on prevention from sharp injuries in the hospital and healthcare sector concluded by HOSPEEM and EPSU (COM(2009)0577). http://www.europarl.europa .eu/sides/getDoc.do?pubRef=-//EP// TEXT+TA+P7-TA-2010-0030 +0+DOC+XML+V0//EN (May 2010, date last accessed).
23. Eumonitor. New legislation to reduce injuries for 3.5 million healthcare workers in Europe. http://www.eumonitor.net/news/archive/146143 (May 2010, date last accessed).